2024 ASCP 40 Under Forty Honoree

Khaleel Al-Obaidy, MBBS, FASCP, D-ABP

Khaleel Al-Obaidy, MBBS, FASCP, D-ABP earned his medical degree from the University of Dammam, Saudi Arabia, in 2012 and soon began an anatomic pathology residency. In 2015, he moved to the United States for pathology residency training, which he followed by a year of head and neck focused-surgical pathology and a year of genitourinary pathology fellowships at Indiana University, and then a molecular genetics pathology fellowship at the Cleveland Clinic. His main focus is on genitourinary tumor diagnosis and research, particularly renal neoplasm classification. During his residency, under the guidance of his mentors, Dr Al-Obaidy identified the first renal tumor with a novel recurrent KRAS mutations, they named “papillary renal neoplasm with reverse polarity,” and discovered a novel molecular alteration in thyroid-like follicular renal cell carcinoma, “EWSR1::PATZ1 fusion.” Over the past few years, he has participated in major pathology conferences with more than 50 abstracts, published more than 40 articles in high-impact peer-reviewed journals, contributed to three book chapters, and was an invited speaker at national and international venues.

Currently, Dr. Al-Obaidy is a senior staff pathologist specializing in genitourinary, head & neck, and molecular pathology at Henry Ford Health in Detroit, MI, and a clinical assistant professor at Michigan State University. He is dedicated to mentoring and guiding medical students and pathology residents, fostering their passion for research and publications. His commitment to advancing medical knowledge is evident through his mentorship and active role in research initiatives.